Literature DB >> 1624684

Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1624684

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  75 in total

1.  Inhibition by somatostatin of ACTH secretion in Nelson's syndrome.

Authors:  J B Tyrrell; M Lorenzi; J E Gerich; P H Forsham
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

2.  Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion.

Authors:  S W Lamberts; S A de Lange; S Z Stefanko
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

3.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Suramin prevents ACTH-stimulated corticosterone release by dispersed adrenocortical cells.

Authors:  H F Marzouk; J Zuyderwijk; P Uitterlinden; F H de Jong; S W Lamberts
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

Review 5.  Distribution of somatostatin receptors in normal and tumor tissue.

Authors:  J C Reubi; L Kvols; E Krenning; S W Lamberts
Journal:  Metabolism       Date:  1990-09       Impact factor: 8.694

6.  Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later.

Authors:  J Hardy
Journal:  Can J Neurol Sci       Date:  1982-11       Impact factor: 2.104

7.  Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.

Authors:  X Bertagna; C Bertagna; M H Laudat; J M Husson; F Girard; J P Luton
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

8.  Effect of sandostatin on CRF-stimulated secretion of ACTH, beta-lipotropin and beta-endorphin.

Authors:  C Invitti; F Pecori Giraldi; A Dubini; M Piolini; F Cavagnini
Journal:  Horm Metab Res       Date:  1991-05       Impact factor: 2.936

9.  Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins.

Authors:  Y C Patel; K K Murthy; E E Escher; D Banville; J Spiess; C B Srikant
Journal:  Metabolism       Date:  1990-09       Impact factor: 8.694

10.  No inhibition of corticotrophin (ACTH)-hypersecretion in adrenal insufficiency by somatostatin.

Authors:  A Jara-Albarrán; J Bayort; A Caballero; R Eusebio; P García-Peris; E Toledano; S Pérez-Modrego
Journal:  Acta Endocrinol (Copenh)       Date:  1980-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.